XML 372 R50.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Subsidiary Preferred Shares (Tables)
12 Months Ended
Dec. 31, 2023
Subsidiary Preferred Shares [Abstract]  
Schedule of Subsidiary Preferred Share Balances
The fair value of all subsidiary preferred shares as of December 31, 2023 and December 31, 2022, is as follows:
2023
$
2022
$
As of December 31,
Entrega169 169 
Follica 350 
Vedanta Biosciences 26,820 
Total subsidiary preferred share balance169 27,339 
Schedule of Subsidiary Preferred Shares, Minimum Liquidation Preference
As of December 31, 2023 and December 31, 2022, the minimum liquidation preference reflecting the amounts that would be payable to the subsidiary preferred holders upon a liquidation event of the subsidiaries, is as follows:
2023
$
2022
$
As of December 31,
Entrega2,216 2,216 
Follica6,405 6,405 
Vedanta Biosciences 149,568 
Total minimum liquidation preference8,621 158,189 
Schedule of Changes in the Value of Subsidiary Preferred Shares
For the years ended December 31, 2023 and 2022, the Group recognized the following changes in the value of subsidiary preferred shares:
$
Balance as of January 1, 2022174,017 
Decrease in value of preferred shares measured at fair value – finance costs (income)(130,825)
Deconsolidation of subsidiary - (Sonde)(15,853)
Balance as of December 31, 202227,339 
Decrease in value of preferred shares measured at fair value – finance costs (income)(2,617)
Deconsolidation of subsidiary – (Vedanta)(24,554)
Balance as of December 31, 2023169